Surescripts and GoodRx Partner to Advance Patient Price Transparency
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence ARLINGTON, Va. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transform the medication experience and empower patients by bringing together prescription benefit data, medication management and personalized engagement. Script Corner will include patient price transparency, including discounted cash prices through an exclusive partnership with GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S.“We believe the future of healthcare is personalized, connected, and truly patient-driven,” said Frank Harvey, Chief Executive Officer of Surescripts. “Surescripts has always championed patient choice—whether it’s the pharmacy they prefer or the tools they use to manage their care. Our new Script Corner
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 [Yahoo! Finance]Yahoo! Finance
- GoodRx (NASDAQ:GDRX) had its price target lowered by analysts at Citigroup Inc. from $5.00 to $4.50. They now have a "buy" rating on the stock.MarketBeat
- GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies [Yahoo! Finance]Yahoo! Finance
- GoodRx Launches RxSmartSaver at Giant Eagle PharmaciesBusiness Wire
- GoodRx (NASDAQ:GDRX) had its "reduce" rating reaffirmed by analysts at UBS Group AG.MarketBeat
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 12/22/25 - Form 4
- GDRX's page on the SEC website